Healthcare
Merit Medical Systems, Inc.(MMSI)
Live Price
Offline$67.22
+3.03% today
1Y Change
-25.31%
Window
Jun 25, 2025 โ Jun 24, 2026
- Market Cap
- $3.70B
- Revenue Growth
- +11.7%
- EPS Growth
- +4.8%
- Dividend Yield
- 0.0%
Coverage: 250 bars ยท Jun 25, 2025 โ Jun 24, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Merit Medical Systems, Inc. (MMSI) is a Healthcare stock with a market cap of $3.70B and listed on NASDAQ. The stock last traded around $67.22 and down 25.3% across the available one-year price window (Jun 25, 2025 โ Jun 24, 2026). Baseline metrics include revenue growth of +11.7%, EPS growth of +4.8%, a dividend yield of 0.0%. What stands out right now is revenue +11.7%, EPS +4.8%, free cash flow +18.0% with operating margin 12.2% and ROIC 5.6%. Valuation is more restrained than many high-expectation growth names at P/E 26.5 and price/sales 2.4. Stock Foundry combines MMSI price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Sector Context
How this name stacks up against nearby peers on first-pass metrics.
Revenue Growth
Above sector median
+11.7% vs +7.6% peer median
Operating Margin
Below sector median
+12.2% vs +19.4% peer median
P/E
Below sector median
26.5 vs 36.3 peer median
What Changed This Quarter
Latest report context and the signals most likely to have changed the story.
Latest report is on the board
2026 was reported on Apr 30, 2026, but the surprise data is still limited.
The operating story is still moving forward
Revenue is running at +11.7% and EPS at +4.8%, with operating margin around 12.2%.
Earnings Reaction Memory
How the stock has tended to move after recent reports.
Across the last 3 reported quarters, the stock averaged -4.5% over the next 5 trading days and finished higher after 1 of those reports.
View quarter-by-quarter reaction table
| Quarter | EPS ฮ | 1D | 5D | 20D |
|---|---|---|---|---|
2026 Apr 30, 2026 | โ | -9.0% | -8.6% | -7.5% |
2026 Feb 24, 2026 | +8.3% | -3.9% | -9.2% | -18.1% |
2025 Oct 30, 2025 | +12.2% | +5.4% | +4.2% | +4.3% |
Benchmark Edge
MMSI vs SPY, QQQ, and Sector ETFs
Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.
MMSI
โ
Normalized return
SPY
--
S&P 500
Excess Return
--
Relative to SPY
MMSI Max Drawdown
-37.18%
Trailing 1Y
SPY Max Drawdown
โ
Trailing 1Y
Calendar-Year Returns
Uses the longest available daily history for MMSI and SPY.
Company Overview
Merit Medical Systems, Inc.
NASDAQ Global Select
Merit Medical Systems, Inc. designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures, primarily in cardiology, radiology, oncology, critical care, and endoscopy. The company operates in two segments, Cardiovascular and Endoscopy. It provides peripheral intervention products for the diagnosis and treatment of diseases in peripheral vessels and organs; and cardiac intervention products, such as access, angiography, electrophysiology and cardiac rhythm management, fluid management, hemodynamic monitoring, hemostasis, and intervention to treat various heart conditions. The company also offers custom procedural solutions that include critical care products, disinfection protection systems, syringes, manifold kits, and trays and packs; coated tubes and wires; and sensor components for microelectromechanical systems. In addition, it provides pulmonary products that consist of laser-cut tracheobronchial stents, over-the-wire and direct visualization delivery systems, and dilation balloons to endoscopically dilate strictures; gastroenterology products; and kits and accessories for endoscopy and bronchoscopy procedures. The company sells its products to hospitals and alternate site-based physicians, technicians, and nurses through direct sales force, distributors, original equipment manufacturer partners, or custom procedure tray manufacturers in the United States and internationally. Merit Medical Systems, Inc. was incorporated in 1987 and is headquartered in South Jordan, Utah.
- Leadership
- Martha Goldberg Aronson
- IPO Date
- May 14, 1990
- Employees
- 7.4k
- Street Address
- 1600 West Merit Parkway
- Mailing
- South Jordan, UT, 84095
- Region
- South Jordan, UT, US
- Reporting Currency
- USD
- Investor Line
- 801 253 1600
- Last Updated
- May 2, 2026
Key Fundamentals
Valuation, growth, profitability, and balance sheet signals.
Valuation
- P/E
- 26.5
- EV/EBITDA
- 14.0
- Price/Sales
- 2.4
- Price/Book
- 2.3
Growth
- Revenue
- +11.7%
- EPS
- +4.8%
- Free Cash Flow
- +18.0%
Profitability
- Gross Margin
- 48.7%
- Operating Margin
- 12.2%
- Net Margin
- 9.0%
- ROE
- 8.9%
- ROIC
- 5.6%
Balance Sheet
- Debt/Equity
- 0.52
- Current Ratio
- 5.08
Earnings Reports
Latest News
Official Releases
Company announcements and filings-style updates.
Next Step
Keep the research moving
After the overview, the strongest next step is usually chart context or a tighter compare set.